−70.9
X4 Pharmaceuticals, Inc
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−77.1
FY23:
−96.5
FY24:
−131
FY25:
−85.6
Change from FY21 to FY25
millions USD
FY21:
−0.62
FY22:
−0.10
FY23:
−14.9
FY24:
67.0
FY25:
8.15
Change from FY21 to FY25
millions USD
FY21:
74.2
FY22:
117
FY23:
88.5
FY24:
20.3
FY25:
239
millions USD
FY21:
2.41
FY22:
39.9
FY23:
−22.8
FY24:
−43.8
FY25:
161
(positive)
Change from FY21 to FY25
millions USD
FY21:
−71.5
FY22:
−77.2
FY23:
−96.6
FY24:
−131
FY25:
−85.6
All amounts in millions USD